المؤلفون: Kengo A; Department of Medicine, Division of Clinical Pharmacology, University of Cape Town , Cape Town, South Africa., Gausi K; Department of Medicine, Division of Clinical Pharmacology, University of Cape Town , Cape Town, South Africa., Nabisere R; Infectious Disease Institute, College of Health Sciences, Makerere University , Kampala, Uganda., Musaazi J; Infectious Disease Institute, College of Health Sciences, Makerere University , Kampala, Uganda., Buzibye A; Infectious Disease Institute, College of Health Sciences, Makerere University , Kampala, Uganda., Omali D; Infectious Disease Institute, College of Health Sciences, Makerere University , Kampala, Uganda., Aarnoutse R; Department of Pharmacy, Radboud university medical center , Nijmegen, the Netherlands., Lamorde M; Infectious Disease Institute, College of Health Sciences, Makerere University , Kampala, Uganda., Dooley KE; Department of Medicine, Division of Infectious Diseases, Vanderbilt University Medical Centre , Nashville, Tennessee, USA., Sloan DJ; Division of Infection and Global Health, School of Medicine, University of St. Andrews , Scotland, United Kingdom., Sekaggya-Wiltshire C; Infectious Disease Institute, College of Health Sciences, Makerere University , Kampala, Uganda., Denti P; Department of Medicine, Division of Clinical Pharmacology, University of Cape Town , Cape Town, South Africa.

المصدر: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2023 Nov 15; Vol. 67 (11), pp. e0043123. Date of Electronic Publication: 2023 Oct 18.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE

مواضيع طبية MeSH: Antibiotics, Antitubercular*/pharmacokinetics , Tuberculosis*/drug therapy , HIV Infections*/drug therapy , Anti-HIV Agents*/pharmacokinetics, Adult ; Humans ; Rifampin/pharmacokinetics ; Uganda ; Benzoxazines/therapeutic use ; Benzoxazines/pharmacokinetics ; Cyclopropanes ; Antitubercular Agents/therapeutic use ; Antitubercular Agents/pharmacokinetics

المؤلفون: Garcia-Prats AJ; Department of Pediatrics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA; Desmond Tutu TB Centre, Department of Paediatics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa. Electronic address: garciaprats@wisc.edu., Hoddinott G; Desmond Tutu TB Centre, Department of Paediatics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa., Howell P; Clinical HIV Research Unit, Sizwe Tropical Disease Hospital, Wits Health Consortium, Department of Internal Medicine, University of the Witwatersrand, Johannesburg, South Africa., Hughes J; Desmond Tutu TB Centre, Department of Paediatics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa., Jean-Philippe P; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Kim S; Department of Biostatistics, Frontier Science Foundation, Brookline, MA, USA., Palmer M; Desmond Tutu TB Centre, Department of Paediatics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa., Schaaf HS; Desmond Tutu TB Centre, Department of Paediatics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa., Seddon JA; Desmond Tutu TB Centre, Department of Paediatics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa; Department of Infectious Disease, Imperial College London, London, UK., Svensson E; Department of Pharmacy, Uppsala University, Uppsala, Sweden; Department of Pharmacy, Research Institute for Medical Innovation, Radboud University Medical Center, Radboud University, Nijmegen, Netherlands., Hesseling AC; Desmond Tutu TB Centre, Department of Paediatics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.

المصدر: The Lancet. Infectious diseases [Lancet Infect Dis] 2023 Jul; Vol. 23 (7), pp. 778-780. Date of Electronic Publication: 2023 May 25.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Tuberculosis, Multidrug-Resistant*/drug therapy , Mycobacterium tuberculosis* , Antibiotics, Antitubercular*/therapeutic use , Antibiotics, Antitubercular*/pharmacology, Child ; Humans ; Rifampin/therapeutic use ; Antitubercular Agents/therapeutic use ; Drug Resistance, Bacterial

المؤلفون: Mhetre UV; Department of Chemistry, Dr. Babasaheb Ambedkar Marathwada University SubCampus, Osmanabad 413501, MS, India., Haval NB; Department of Chemistry, Dr. Babasaheb Ambedkar Marathwada University, Aurangabad 431004, MS, India., Bondle GM; Department of Chemistry, Dr. Babasaheb Ambedkar Marathwada University, Aurangabad 431004, MS, India., Rathod SS; Department of Pharmaceutical Chemistry, Bharati Vidyapeeth College of Pharmacy, Kolhapur 416013, MS, India., Choudhari PB; Department of Pharmaceutical Chemistry, Bharati Vidyapeeth College of Pharmacy, Kolhapur 416013, MS, India., Kumari J; Department of Pharmacy, Birla Institute of Technology and Science-Pilani, Hyderabad Campus, Jawahar Nagar, Shameerpet Mandal, R. R. District, Hyderabad 500078, India., Sriram D; Department of Pharmacy, Birla Institute of Technology and Science-Pilani, Hyderabad Campus, Jawahar Nagar, Shameerpet Mandal, R. R. District, Hyderabad 500078, India., Haval KP; Department of Chemistry, Dr. Babasaheb Ambedkar Marathwada University SubCampus, Osmanabad 413501, MS, India. Electronic address: havalkp@gmail.com.

المصدر: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2024 Aug 01; Vol. 108, pp. 129800. Date of Electronic Publication: 2024 May 17.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9107377 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-3405 (Electronic) Linking ISSN: 0960894X NLM ISO Abbreviation: Bioorg Med Chem Lett Subsets: MEDLINE

مواضيع طبية MeSH: Antitubercular Agents*/pharmacology , Antitubercular Agents*/chemical synthesis , Antitubercular Agents*/chemistry , Molecular Docking Simulation* , Antimalarials*/pharmacology , Antimalarials*/chemical synthesis , Antimalarials*/chemistry , Triazoles*/chemistry , Triazoles*/pharmacology , Triazoles*/chemical synthesis , Mycobacterium tuberculosis*/drug effects , Drug Design* , Plasmodium falciparum*/drug effects , Quinazolinones*/chemistry , Quinazolinones*/pharmacology , Quinazolinones*/chemical synthesis , Microbial Sensitivity Tests*, Mice ; Structure-Activity Relationship ; Animals ; Molecular Structure ; Dose-Response Relationship, Drug ; RAW 264.7 Cells

المؤلفون: Maranchick NF; Infectious Disease Pharmacokinetics Lab, Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, USA.; Emerging Pathogens Institute, University of Florida, Gainesville, USA., Kwara A; Emerging Pathogens Institute, University of Florida, Gainesville, USA.; Division of Infectious Diseases and Global Medicine, College of Medicine, University of Florida, Gainesville, USA., Peloquin CA; Infectious Disease Pharmacokinetics Lab, Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, USA.; Emerging Pathogens Institute, University of Florida, Gainesville, USA.

المصدر: Expert review of clinical pharmacology [Expert Rev Clin Pharmacol] 2024 Jul; Vol. 17 (7), pp. 537-547. Date of Electronic Publication: 2024 Feb 14.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101278296 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1751-2441 (Electronic) Linking ISSN: 17512433 NLM ISO Abbreviation: Expert Rev Clin Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Drug Interactions* , Tuberculosis*/drug therapy , HIV Infections*/drug therapy , HIV Infections*/complications , Antitubercular Agents*/administration & dosage , Antitubercular Agents*/adverse effects , Antitubercular Agents*/pharmacokinetics , Antitubercular Agents*/pharmacology , Anti-HIV Agents*/administration & dosage , Anti-HIV Agents*/adverse effects , Anti-HIV Agents*/pharmacokinetics , Drug Monitoring*/methods, Humans ; Rifamycins/administration & dosage ; Rifamycins/pharmacokinetics ; Rifamycins/adverse effects

المؤلفون: Shimizu T; Department of Dermatology, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa 259-1193, Japan. shimizu.t@tokai.ac.jp., Hirota A, Takahashi N, Okaniwa A, Saito R, Saito N, Kondoh A, Yamazaki F, Toshima S, Mabuchi T

المصدر: The Tokai journal of experimental and clinical medicine [Tokai J Exp Clin Med] 2024 Sep 20; Vol. 49 (3), pp. 101-104. Date of Electronic Publication: 2024 Sep 20.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Tokai University School Of Medicine Country of Publication: Japan NLM ID: 7704186 Publication Model: Electronic Cited Medium: Internet ISSN: 2185-2243 (Electronic) Linking ISSN: 03850005 NLM ISO Abbreviation: Tokai J Exp Clin Med Subsets: MEDLINE

مواضيع طبية MeSH: Arthritis, Rheumatoid*/drug therapy , Arthritis, Rheumatoid*/complications , Janus Kinase Inhibitors*/adverse effects , Antitubercular Agents*/adverse effects , Antitubercular Agents*/administration & dosage , Sulfonamides*/adverse effects , Sulfonamides*/administration & dosage , Pyrazoles*/adverse effects , Tuberculosis, Lymph Node*/drug therapy , Tuberculosis, Lymph Node*/diagnosis, Humans ; Female ; Aged ; Purines/adverse effects ; Purines/administration & dosage ; Azetidines/adverse effects ; Azetidines/administration & dosage ; Tuberculosis, Cutaneous/diagnosis ; Tuberculosis, Cutaneous/drug therapy ; Treatment Outcome ; Mycobacterium tuberculosis/isolation & purification ; Drug Therapy, Combination ; Isoniazid/adverse effects ; Isoniazid/administration & dosage

المؤلفون: Opperman M; Human Metabolomics, North-West University (Potchefstroom Campus), Private Bag x6001, Box 269, Potchefstroom 2531, South Africa., Mason S; Human Metabolomics, North-West University (Potchefstroom Campus), Private Bag x6001, Box 269, Potchefstroom 2531, South Africa., van der Westhuizen J; Human Metabolomics, North-West University (Potchefstroom Campus), Private Bag x6001, Box 269, Potchefstroom 2531, South Africa., Loots DT; Human Metabolomics, North-West University (Potchefstroom Campus), Private Bag x6001, Box 269, Potchefstroom 2531, South Africa., du Preez I; Human Metabolomics, North-West University (Potchefstroom Campus), Private Bag x6001, Box 269, Potchefstroom 2531, South Africa. Electronic address: Ilse.DuPreez@nwu.ac.za.

المصدر: Journal of pharmaceutical and biomedical analysis [J Pharm Biomed Anal] 2024 Sep 15; Vol. 248, pp. 116297. Date of Electronic Publication: 2024 Jun 10.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Country of Publication: England NLM ID: 8309336 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-264X (Electronic) Linking ISSN: 07317085 NLM ISO Abbreviation: J Pharm Biomed Anal Subsets: MEDLINE

مواضيع طبية MeSH: Antitubercular Agents*/urine , Antitubercular Agents*/therapeutic use , Antitubercular Agents*/analysis , Treatment Failure* , Tuberculosis*/drug therapy , Tuberculosis*/urine, Humans ; Male ; Adult ; Female ; Proton Magnetic Resonance Spectroscopy/methods ; Middle Aged ; Pyrazinamide/urine ; Ethambutol/urine ; Magnetic Resonance Spectroscopy/methods ; Isoniazid/urine ; Aged

المؤلفون: Wallis RS; The Aurum Institute, Johannesburg.; Department of Medicine, Case Western Reserve University, Cleveland.; Department of Medicine, Vanderbilt University, Nashville., Sabi I; National Institute for Medical Research-Mbeya Medical Research Center, Mbeya, Tanzania., Lalashowi J; National Institute for Medical Research-Mbeya Medical Research Center, Mbeya, Tanzania., Bakuli A; Institute of Infectious Diseases and Tropical Medicine, Ludwig Maximilian University Hospital, Munich, Germany., Mapamba D; National Institute for Medical Research-Mbeya Medical Research Center, Mbeya, Tanzania., Olomi W; National Institute for Medical Research-Mbeya Medical Research Center, Mbeya, Tanzania., Siyame E; National Institute for Medical Research-Mbeya Medical Research Center, Mbeya, Tanzania., Ngaraguza B; National Institute for Medical Research-Mbeya Medical Research Center, Mbeya, Tanzania., Chimbe O; National Institute for Medical Research-Mbeya Medical Research Center, Mbeya, Tanzania., Charalambous S; The Aurum Institute, Johannesburg.; Department of Medicine, Vanderbilt University, Nashville., Rachow A; Institute of Infectious Diseases and Tropical Medicine, Ludwig Maximilian University Hospital, Munich, Germany.; German Centre for Infection Research, Partner Site Munich, Munich, Germany.; Unit Global Health, Helmholtz Zentrum München, German Research Center for Environmental Health (HMGU), Neuherberg, Germany., Ivanova O; Institute of Infectious Diseases and Tropical Medicine, Ludwig Maximilian University Hospital, Munich, Germany.; German Centre for Infection Research, Partner Site Munich, Munich, Germany.; Unit Global Health, Helmholtz Zentrum München, German Research Center for Environmental Health (HMGU), Neuherberg, Germany., Zurba L; Education for Health Africa, Durban, South Africa., Myombe B; National Institute for Medical Research-Mbeya Medical Research Center, Mbeya, Tanzania., Kunambi R; National Institute for Medical Research-Mbeya Medical Research Center, Mbeya, Tanzania., Hoelscher M; Institute of Infectious Diseases and Tropical Medicine, Ludwig Maximilian University Hospital, Munich, Germany.; German Centre for Infection Research, Partner Site Munich, Munich, Germany.; Unit Global Health, Helmholtz Zentrum München, German Research Center for Environmental Health (HMGU), Neuherberg, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP; Immunology, Infection and Pandemic Research, Munich, Germany., Ntinginya N; National Institute for Medical Research-Mbeya Medical Research Center, Mbeya, Tanzania., Churchyard G; The Aurum Institute, Johannesburg.; Department of Medicine, Vanderbilt University, Nashville.

المصدر: NEJM evidence [NEJM Evid] 2024 Sep; Vol. 3 (9), pp. EVIDoa2300332. Date of Electronic Publication: 2024 Aug 27.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: NEJM Group, a division of the Massachusetts Medical Society Country of Publication: United States NLM ID: 9918317485806676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2766-5526 (Electronic) Linking ISSN: 27665526 NLM ISO Abbreviation: NEJM Evid Subsets: MEDLINE

مواضيع طبية MeSH: Acetylcysteine*/administration & dosage , Acetylcysteine*/therapeutic use , Tuberculosis, Pulmonary*/drug therapy , Antitubercular Agents*/therapeutic use , Antitubercular Agents*/administration & dosage , Glutathione*/blood, Humans ; Male ; Female ; Adult ; Prospective Studies ; Middle Aged ; Lung/drug effects ; Lung/microbiology ; Lung/physiopathology ; Sputum/microbiology ; Treatment Outcome ; Respiratory Function Tests ; Young Adult

المؤلفون: Cevik M; Division of Infection and Global Health Research, School of Medicine, University of St Andrews, Fife, Scotland., Sturdy A; Department of Infectious Disease, Faculty of Medicine, Imperial College London, UK., Maraolo AE; Department of Clinical Medicine and Surgery, Section of Infectious Diseases, University of Naples 'Federico II', Italy., Dekkers BGJ; University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen., Akkerman OW; University of Groningen, University Medical Center Groningen, Department of Pulmonary Diseases and Tuberculosis, Groningen, University of Groningen, University Medical Center Groningen, Tuberculosis Center Beatrixoord, Haren, the Netherlands., Gillespie SH; Division of Infection and Global Health Research, School of Medicine, University of St Andrews, Fife, Scotland., Alffenaar JWC; The University of Sydney Institute for Infectious Diseases, Sydney, NSW, School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Westmead Hospital, Westmead, NSW, Australia

المصدر: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease [Int J Tuberc Lung Dis] 2024 Sep 01; Vol. 28 (9), pp. 454-460.

نوع المنشور: Systematic Review; Journal Article; Meta-Analysis

بيانات الدورية: Publisher: International Union against Tuberculosis and Lung Disease Country of Publication: France NLM ID: 9706389 Publication Model: Print Cited Medium: Internet ISSN: 1815-7920 (Electronic) Linking ISSN: 10273719 NLM ISO Abbreviation: Int J Tuberc Lung Dis Subsets: MEDLINE

مواضيع طبية MeSH: Antitubercular Agents*/pharmacokinetics , Antitubercular Agents*/administration & dosage , Diabetes Mellitus*/drug therapy , Tuberculosis*/drug therapy, Humans ; Rifampin/pharmacokinetics ; Rifampin/administration & dosage ; Isoniazid/pharmacokinetics ; Isoniazid/administration & dosage ; Pyrazinamide/pharmacokinetics

المؤلفون: Khan A; Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Pulau Pinang, Malaysia., Khan AH; Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Pulau Pinang, Malaysia. Electronic address: dramer@usm.my., Ahmad N; Department of Pharmacy Practice, Faculty of Biological, Pharmaceutical and Health Sciences, University of Balochistan, Quetta, Pakistan., Ghafoor A; National TB Control Program, Islamabad, Pakistan.

المصدر: Journal of infection and public health [J Infect Public Health] 2024 Sep; Vol. 17 (9), pp. 102522. Date of Electronic Publication: 2024 Aug 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101487384 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1876-035X (Electronic) Linking ISSN: 18760341 NLM ISO Abbreviation: J Infect Public Health Subsets: MEDLINE

مواضيع طبية MeSH: Antitubercular Agents*/therapeutic use , Antitubercular Agents*/administration & dosage , Tuberculosis, Multidrug-Resistant*/drug therapy , Diarylquinolines*/therapeutic use , Diarylquinolines*/administration & dosage , Rifampin*/therapeutic use , Rifampin*/administration & dosage, Humans ; Female ; Male ; Retrospective Studies ; Adult ; Pakistan ; Middle Aged ; Treatment Outcome ; Young Adult ; Administration, Oral ; Adolescent ; Aged

المؤلفون: Thomas L; Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education (MAHE), Manipal, Karnataka, 576104, India., Raju AP; Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education (MAHE), Manipal, Karnataka, 576104, India., Mallayasamy S; Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education (MAHE), Manipal, Karnataka, 576104, India., Rao M; Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education (MAHE), Manipal, Karnataka, 576104, India. mahadev.rao@manipal.edu.

المصدر: European journal of drug metabolism and pharmacokinetics [Eur J Drug Metab Pharmacokinet] 2024 Sep; Vol. 49 (5), pp. 541-557. Date of Electronic Publication: 2024 Aug 17.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Springer France Country of Publication: France NLM ID: 7608491 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2107-0180 (Electronic) Linking ISSN: 03787966 NLM ISO Abbreviation: Eur J Drug Metab Pharmacokinet Subsets: MEDLINE

مواضيع طبية MeSH: Antitubercular Agents*/pharmacokinetics , Antitubercular Agents*/administration & dosage , Antitubercular Agents*/adverse effects , Precision Medicine*/methods , Isoniazid*/pharmacokinetics , Isoniazid*/administration & dosage , Isoniazid*/adverse effects , Tuberculosis*/drug therapy , Tuberculosis*/microbiology , Mycobacterium tuberculosis*/drug effects , Mycobacterium tuberculosis*/genetics, Humans ; Drug Monitoring/methods ; Arylamine N-Acetyltransferase/genetics ; Arylamine N-Acetyltransferase/metabolism ; Pharmacogenetics ; Drug Resistance, Bacterial/genetics